FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Unsure of Unprecedented Jemperli Trial Plans

FDA medical reviewers raise concerns about GlaxoSmithKlines proposed trials of Jemperli to support a future BLA accelerated approval for some rectal c...

latest-news-card-1
Medical Devices

Industry VMSR Improvement Suggestions

Two medical device associations suggest ways to improve an FDA draft guidance on the Voluntary Malfunction Summary Reporting program created under MDU...

latest-news-card-1
Human Drugs

CDER Researches Convolutional Neural Networks

CDER describes a research study using flow microscopy and convolutional neural networks to monitor changes in product quality attributes.

Medical Devices

DiA Imagings AI Imaging Software Cleared

FDA clears a DiA Imaging Analysis 510(k) for its LVivo IQS, a new artificial intelligence-based vendor-neutral software intended to help users in acqu...

latest-news-card-1
Medical Devices

Universal Meditech Recalls Covid Tests

Universal Meditech recalls (Class 1) its Skippack Medical Lab Covid-19 Direct Antigen Rapid Tests (Colloidal Gold) because they did not have FDA autho...

latest-news-card-1
FDA General

Califf Sails Through 1st Covid Oversight Hearing

FDA commissioner Robert Califf easily manages criticisms of the agencys handling of the Covid-19 pandemic during a 2/8 House Energy and Commerce joint...

latest-news-card-1
Biologics

Cell and Tissue Deviations at Palm Beach Fertility Center

FDA warns the Palm Beach Fertility Center about significant repeat deviations from cellular and tissue regulations.

latest-news-card-1
Medical Devices

FDA Criminal Probe Nets Device Maker Indictment

An FDA Office of Criminal Investigations probe leads to a Puerto Rico federal grand jury indictment against Magnetic Healer and three individuals char...

latest-news-card-1
Federal Register

Cell/Gene Therapy Advisory Committee Renewed

Federal Register notice: FDA announces the renewal of its Cellular, Tissue, and Gene Therapies Advisory Committee for an additional two years beyond i...

latest-news-card-1
FDA General

8 Inspection Takeaways from New FDA Law

Two former FDAers list eight key takeaways from the new FDA Omnibus Reform Act.